Espoo, Finland

Anni Warri


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Location History:

  • 21420 Lieto, FI (1998)
  • Espoo, FI (1999 - 2002)
  • SF-02101 Espoo, FI (2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Anni Warri from Espoo, FI

Introduction

Anni Warri, a talented inventor based in Espoo, Finland, has made significant contributions to the field of medicine. With a total of six patents to her name, she is recognized for her innovative approaches to treating complex health conditions, particularly autoimmune diseases.

Latest Patents

Among her notable inventions, Anni has developed breakthrough remedies for autoimmune diseases. She has disclosed the use of nonsteroidal anti-estrogen compounds, specifically torremifene citrate, as an active ingredient for treating these challenging conditions. This innovative approach showcases her commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Anni's career is marked by her work with various reputable organizations. Notably, she has been associated with Nippon Kayaku Kabushiki Kaisha, where she has further honed her expertise in pharmacological advancements. Her work reflects a dedication to innovation and improvement in therapeutic options available for patients.

Collaborations

Throughout her career, Anni has collaborated with esteemed professionals in the field, including Osamu Miyazaki and Hisao Ekimoto. These partnerships have played a crucial role in her development of groundbreaking remedies, exemplifying the importance of teamwork in the innovation process.

Conclusion

Anni Warri's contributions to the field of medicine, particularly through her patents on autoimmune disease treatments, highlight her status as a prominent inventor. Her innovative spirit and collaborative efforts with other experts in the industry continue to inspire advancements in healthcare and patient treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…